Biotech & Pharma

Cell Therapy Company Aims to Pioneer Analytics Automation

27 sec read7 views0 listens

BlueRock Therapeutics has created an automated system for high-throughput auditing of cell therapies, addressing a gap in existing solutions. This development is crucial for tech professionals as it pushes the boundaries of automation in a relatively new therapeutic modality, potentially lowering costs through reduced sample volumes and reagent usage. Other companies are encouraged to follow suit, driving further innovation in the field.

Read the full article at Genetic Engineering News


Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Views7
Ali Nemati
Ali NematiBlogUI.author_articles
BlogUI.view_profile